Correlation Between Panbela Therapeutics and Prometheus Biosciences
Can any of the company-specific risk be diversified away by investing in both Panbela Therapeutics and Prometheus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Panbela Therapeutics and Prometheus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Panbela Therapeutics and Prometheus Biosciences, you can compare the effects of market volatilities on Panbela Therapeutics and Prometheus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Panbela Therapeutics with a short position of Prometheus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Panbela Therapeutics and Prometheus Biosciences.
Diversification Opportunities for Panbela Therapeutics and Prometheus Biosciences
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Panbela and Prometheus is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Panbela Therapeutics and Prometheus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prometheus Biosciences and Panbela Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Panbela Therapeutics are associated (or correlated) with Prometheus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prometheus Biosciences has no effect on the direction of Panbela Therapeutics i.e., Panbela Therapeutics and Prometheus Biosciences go up and down completely randomly.
Pair Corralation between Panbela Therapeutics and Prometheus Biosciences
If you would invest 19,992 in Prometheus Biosciences on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Prometheus Biosciences or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Panbela Therapeutics vs. Prometheus Biosciences
Performance |
| Timeline |
| Panbela Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Prometheus Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Panbela Therapeutics and Prometheus Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Panbela Therapeutics and Prometheus Biosciences
The main advantage of trading using opposite Panbela Therapeutics and Prometheus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Panbela Therapeutics position performs unexpectedly, Prometheus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prometheus Biosciences will offset losses from the drop in Prometheus Biosciences' long position.| Panbela Therapeutics vs. ZyVersa Therapeutics | Panbela Therapeutics vs. Sonnet Biotherapeutics Holdings | Panbela Therapeutics vs. Revelation Biosciences | Panbela Therapeutics vs. Altamira Therapeutics |
| Prometheus Biosciences vs. Apellis Pharmaceuticals | Prometheus Biosciences vs. Akero Therapeutics | Prometheus Biosciences vs. Immunovant | Prometheus Biosciences vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |